Feifei Gu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism.
Journal: International journal of oncology
Published: August 28, 2025
C1QBP-STAT1 Interaction Promotes Activation of the c-Myc-CHK1/CHK2 Signaling Axis and Radioresistance in Lung Cancer.
Journal: Molecular cancer research : MCR
Published: July 30, 2025
Corrigendum: Comprehensive profiling reveals distinct microenvironment and metabolism characterization of lung adenocarcinoma.
Journal: Frontiers in genetics
Published: February 28, 2025
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad18.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 09, 2024
Immunotherapy beyond progression following first‑line chemotherapy plus immunotherapy in advanced non‑small cell lung cancer: A retrospective study.
Journal: Oncology letters
Published: July 25, 2024
OTUB1 Targets CHK1 for Deubiquitination and Stabilization to Facilitate Lung Cancer Progression and Radioresistance.
Journal: International journal of radiation oncology, biology, physics
Published: August 21, 2023
Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
Journal: Journal of cancer research and clinical oncology
Published: June 01, 2023
Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in cell and developmental biology
Published: September 02, 2021
Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3-4 NSCLC patients.
Journal: BMC medical genomics
Published: March 17, 2021
The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study.
Journal: Technology in cancer research & treatment
Published: March 15, 2021
Identification of CXCL13/CXCR5 axis's crucial and complex effect in human lung adenocarcinoma.
Journal: International immunopharmacology
Published: November 06, 2020
Last Updated: 09/26/2026